270 related articles for article (PubMed ID: 30682900)
21. Endocapillary hypercellularity levels are associated with early complete remission in children with class IV lupus nephritis as the initial presentation of SLE.
Li C; Han Y; Zhang L; Chen Z; Jin M; Sun S
BMC Nephrol; 2022 Aug; 23(1):296. PubMed ID: 36008770
[TBL] [Abstract][Full Text] [Related]
22. Combined low-dose mycophenolate mofetil and tacrolimus for lupus nephritis with suboptimal response to standard therapy: a 12-month prospective study.
Mok CC; To CH; Yu KL; Ho LY
Lupus; 2013 Oct; 22(11):1135-41. PubMed ID: 23995863
[TBL] [Abstract][Full Text] [Related]
23. Renal response and its predictive factors of lupus nephritis: a 2-year real-world study of 56 hospital-based patients.
Du K; Zhang X; Feng J; Zhong S; Qi J; Lin Z
Clin Rheumatol; 2022 Nov; 41(11):3363-3371. PubMed ID: 35854166
[TBL] [Abstract][Full Text] [Related]
24. Retrospective analysis of nephritis response and renal outcome in a cohort of 928 Egyptian lupus nephritis patients: a university hospital experience.
Momtaz M; Fayed A; Wadie M; Gamal SM; Ghoniem SA; Sobhy N; Kamal Elden NM; Hamza WM
Lupus; 2017 Dec; 26(14):1564-1570. PubMed ID: 28625079
[TBL] [Abstract][Full Text] [Related]
25. Predictive factors for low rate of remission in a population of Colombian patients with severe proliferative lupus nephritis.
Pinto-Peñaranda LF; Duque-Caballero V; Márquez-Hernández JD; Muñoz-Grajales C; Velásquez-Franco CJ
Clin Rheumatol; 2015 May; 34(5):897-903. PubMed ID: 25592376
[TBL] [Abstract][Full Text] [Related]
26. Rituximab as add-on therapy in patients with resistant lupus nephritis who have failed induction or maintenance therapy with other agents: A real-world experience from a single center in Mumbai.
Yadav S; Balakrishnan C; Mangat G; Kothari J
Lupus; 2024 Jan; 33(1):88-95. PubMed ID: 38048588
[TBL] [Abstract][Full Text] [Related]
27. A prospective observational cohort study highlights kidney biopsy findings of lupus nephritis patients in remission who flare following withdrawal of maintenance therapy.
De Rosa M; Azzato F; Toblli JE; De Rosa G; Fuentes F; Nagaraja HN; Nash R; Rovin BH
Kidney Int; 2018 Oct; 94(4):788-794. PubMed ID: 30045812
[TBL] [Abstract][Full Text] [Related]
28. Remission of proteinuria indicates good prognosis in patients with diffuse proliferative lupus nephritis.
Koo HS; Kim S; Chin HJ
Lupus; 2016 Jan; 25(1):3-11. PubMed ID: 26159540
[TBL] [Abstract][Full Text] [Related]
29. Mizoribine for the treatment of lupus nephritis in children and adolescents.
Tanaka H; Tsugawa K; Tsuruga K; Suzuki K; Nakahata T; Ito E; Waga S
Clin Nephrol; 2004 Dec; 62(6):412-7. PubMed ID: 15630899
[TBL] [Abstract][Full Text] [Related]
30. Cyclosporine for the treatment of lupus nephritis in patients with systemic lupus erythematosus.
Yang TH; Wu TH; Chang YL; Liao HT; Hsu CC; Tsai CY; Chou YC
Clin Nephrol; 2018 Apr; 89(4):277-285. PubMed ID: 29319493
[TBL] [Abstract][Full Text] [Related]
31. Mycophenolate mofetil versus azathioprine in the maintenance therapy of lupus nephritis.
Sahin GM; Sahin S; Kiziltas S; Masatlioglu S; Oguz F; Ergin H
Ren Fail; 2008; 30(9):865-9. PubMed ID: 18925525
[TBL] [Abstract][Full Text] [Related]
32. Prednisone monotherapy induced remission in a group of patients with membranous lupus nephritis.
Bitencourt Dias C; Pinheiro CC; Malafronte P; Titan S; Alves de Brito G; Gera Abrão J; Dos Santos Silva V; Toledo Barros R; Woronik V
Clin Nephrol; 2011 Jul; 76(1):57-63. PubMed ID: 21722606
[TBL] [Abstract][Full Text] [Related]
33. Leflunomide versus cyclophosphamide in the induction treatment of proliferative lupus nephritis in Chinese patients: a randomized trial.
Zhang M; Qi C; Zha Y; Chen J; Luo P; Wang L; Sun Z; Wan J; Xing C; Wang S; Jiang G; Sun M; Chen Q; Chen J; Li D; Guan T; Ni Z
Clin Rheumatol; 2019 Mar; 38(3):859-867. PubMed ID: 30426311
[TBL] [Abstract][Full Text] [Related]
34. Complete renal response at 12 months after induction therapy is associated with renal relapse-free rate in lupus nephritis: a single-center, retrospective cohort study.
Ichinose K; Kitamura M; Sato S; Eguchi M; Okamoto M; Endo Y; Tsuji S; Takatani A; Shimizu T; Umeda M; Fukui S; Sumiyoshi R; Koga T; Kawashiri S; Iwamoto N; Igawa T; Tamai M; Nakamura H; Origuchi T; Nishino T; Kawakami A
Lupus; 2019 Apr; 28(4):501-509. PubMed ID: 30755146
[TBL] [Abstract][Full Text] [Related]
35. Efficacy and safety of multitarget therapy with cyclophosphamide and tacrolimus for lupus nephritis: a prospective, single-arm, single-centre, open label pilot study in Japan.
Sakai R; Kurasawa T; Nishi E; Kondo T; Okada Y; Shibata A; Nishimura K; Chino K; Okuyama A; Takei H; Nagasawa H; Amano K
Lupus; 2018 Feb; 27(2):273-282. PubMed ID: 28683654
[TBL] [Abstract][Full Text] [Related]
36. Tacrolimus versus mycophenolate mofetil for induction therapy of lupus nephritis: a randomised controlled trial and long-term follow-up.
Mok CC; Ying KY; Yim CW; Siu YP; Tong KH; To CH; Ng WL
Ann Rheum Dis; 2016 Jan; 75(1):30-6. PubMed ID: 25550339
[TBL] [Abstract][Full Text] [Related]
37. International cohort of 382 children with lupus nephritis - presentation, treatment and outcome at 24 months.
De Mutiis C; Wenderfer SE; Basu B; Bagga A; Orjuela A; Sar T; Aggarwal A; Jain A; Yap HK; Teo S; Ito S; Ohnishi A; Iwata N; Kasapcopur O; Yildiz M; Laurent A; Mastrangelo A; Ogura M; Shima Y; Rianthavorn P; Silva CA; Trindade V; Gianviti A; Akinori M; Hamada R; Fujimura J; Minamikawa S; Kamiyoshi N; Kaito H; Ishimori S; Iannuzzella F; Tullus K
Pediatr Nephrol; 2023 Nov; 38(11):3699-3709. PubMed ID: 37221349
[TBL] [Abstract][Full Text] [Related]
38. The short-term efficacy of bortezomib combined with glucocorticoids for the treatment of refractory lupus nephritis.
Zhang H; Liu Z; Huang L; Hou J; Zhou M; Huang X; Hu W; Liu Z
Lupus; 2017 Aug; 26(9):952-958. PubMed ID: 28059023
[TBL] [Abstract][Full Text] [Related]
39. Rituximab alone as induction therapy for membranous lupus nephritis: A multicenter retrospective study.
Chavarot N; Verhelst D; Pardon A; Caudwell V; Mercadal L; Sacchi A; Leonardi C; Le Guern V; Karras A; Daugas E;
Medicine (Baltimore); 2017 Jul; 96(27):e7429. PubMed ID: 28682905
[TBL] [Abstract][Full Text] [Related]
40. Correlation of urine protein/creatinine ratios to 24-h urinary protein for quantitating proteinuria in children.
Huang Y; Yang X; Zhang Y; Yue S; Mei X; Bi L; Zhai W; Ren X; Ding Y; Zhang S; Deng Z; Sun Y
Pediatr Nephrol; 2020 Mar; 35(3):463-468. PubMed ID: 31813022
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
